New study examines soaring drug prices

Drug prices have long been a widely debated topic. In a new British study, researchers argue that pharmaceutical companies cannot use high development costs as motivation  for the soaring prices — especially as most new drugs provide  rather limited improvements in clinical benefit compared to  existing treatments.

Read the full article at biostock.se:

https://www.biostock.se/en/2023/02/new-study-examines-soaring-drug-prices/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se